By contrast, collagen IV coating did not affect ER+ and HER2+ cell lines.<h4>Conclusions</h4>Abundance of stromal collagen IV increases risk of dying in breast cancer after DCIS, and collagen IV can promote cell motility in vitro. Here, ERBB2 is linked to breast cancer.